Argentina vs Cuba: Previously treated cases tested for RR-/MDR-TB
Argentina
61.0%
in 2024
Cuba
61.0%
in 2024
Argentina rank
136th
Cuba rank
136th
Previously treated cases tested for RR-/MDR-TB over time
- Argentina
- Cuba
How they compare
Argentina currently reports 61.0% against 61.0% in Cuba, a difference of 0.0%.
The two have swapped places 3 times across 14 shared years of data; in 2005 it was Argentina ahead.
Argentina ranks 136th and Cuba ranks 136th of 180 countries.
Across the 3 decades both report, Argentina averaged higher in 1 and Cuba in 2.
Head to head by decade
| Decade | Argentina | Cuba | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 39.0% | 61.0% | Argentina |
| 2010s | 31.3% | 70.2% | 39.0% | Cuba |
| 2020s | 48.4% | 53.4% | 5.0% | Cuba |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Argentina or Cuba?
- Argentina, at 61.0% against 61.0% in Cuba as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Argentina and Cuba?
- 0.0%, with Argentina ahead.
- How many years of comparable data are there for Argentina and Cuba?
- 14 years are reported by both, from 2005 to 2024.
- How do Argentina and Cuba rank globally for previously treated cases tested for rr-/mdr-tb?
- Argentina ranks 136th and Cuba ranks 136th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.